$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
Morgan Healthcare Conference when Celgene acquired San Diego-based Impact Biomedicines and its JAK inhibitor program targeting myelofibrosis. In March, GlaxoSmithKline dropped $13 billion to acquire full control of a consumer health unit. Last year the healthcare unit reported sales of nearly $11 billion (£7.8
40 
Let's personalize your content